NASDAQ Biotech Prospects: Targeting Oncology and Gastrointestinal Markets
Biotechnology firms consistently draw investor attention due to their potential to disrupt established medical treatments. Take Shuttle Pharmaceuticals Holdings Inc. (NASDAQ: SHPH), a clinical-stage company currently navigating the highly volatile micro-cap space. With a market […]








